RoyDJ (ed). Care: The Moral MandateJ Palliat Care1988; 4: 3–4.
2.
AmentaMO, TehanCB (eds).: Special issue: AIDS and the hospice communityHospice J1991; 7: 1–187.
3.
von GuntenCF, MartinezJ, WeitzmanS, Von RoennJ.: AIDS and hospiceAm J Hospice Palliat Care1991; 8: 17–19.
4.
LethemW.Mouth and skin problems in the management of terminal malignant disease. In: SandersC, SykesW (eds). Boston:Hodder and Stoughton, 1993; pp. 140–141.
YarchoenR, MitsuyaM, MyersCE, BroderS.: Clinical pharmacology of 3-azido-2,3-dideoxythymidine (zidovudine) and related dideoxynucleosidesNew Engl J Med1989; 321: 726–748.
7.
BroderS, MitsuyaM, YarchonR, PavlakisGN.: Antiretroviral therapy in AIDSAnn Int Med1990; 113: 604–618.
8.
Studies of Ocular Complications of AIDS Research Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. New Engl J Med1992; 326: 213–220.
9.
Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with HIV. JAMA1992; 267: 2294–2299.
10.
HickeyMS, WeaverKE.: Nutritional management of patients with ARC or AIDSGastroint Clin N Am1988; 17: 545–561.
11.
SandersC, BainsM.Living With Dying.New York:Oxford Medical Publications, 1989.